Paul Ehrlich Paul Ehrlich Euro-PhD Network & MuTaLig COST Action meeting 2019
Catanzaro (Italy), June 13th-15th 2019
COST
     
Home

Registration

Scientific
Program


Poster
Gallery


Book of
Abstract


Social
Program


Committees

Venue

Deadline
and News


Photo
Gallery


N4S

IMPREMED

Inte:Ligand

SCHRODINGER

CCIA

CATANZARO CITY

LA CASCINA

SCOZIA ARREDA

AMC

FEDERFARMA

List of accepted poster communications


SURNAME

Name

Title

ALTERIO

Vincenzo

X-ray crystal structure of carbonic anhydrase XII complexed with a theranostic monoclonal antibody fragment

AMBROSIO

Francesca Alessandra

Compounds Targeting the RNA-Binding Protein HuR. Structure-Based Design, Synthesis and Interaction Studies.

BARBAROSSA

Alexia

Benzothienoquinazolinones as new inhibitor of Topoisomerases and Tubulin

BARONISSI

Giuliana

Design, synthesis and pharmacological characterization of novel potent non-steroidal agonists of the farnesoid X receptor

BARROS SILVA

Tiago

Hydroxypyridin-4-ones are a versatile scaffold to develop copper(II)-chelating COMT inhibitors with neuroprotective properties

BOU PETIT

Elisabeth

Study of pyrazolo[3,4-b]pyridin-6-one and pyrazolo[3,4-b]-pyridine scaffolds as MNK inhibitors

BOUTON

Jakob

3’-Deoxy-3’-fluoro-7-deazapurine nucleosides: synthesis and evaluation against kinetoplastid parasites

CAGIDE

Fernando

Development of new antibiotics based on natural scaffolds

CATALANO

Raffaella

Metabolites prediction at the Mu.Ta.Lig. Chemotheca

CERAMELLA

Jessica

Interesting biological properties of Anchusa azurea Mill. (Boraginaceae) methanol extract

CORICELLO

Adriana

Upcoming targets in neurodegenerative diseases: a molecular recognition study.

COSTANZO

Paola

New donepezil-like multi-target directed ligands for Alzheimer’s Disease based on hydroxytyrosol

DI FIORE

Anna

Exploring conformational variability of benzoxaborole derivatives for the development of selective carbonic anhydrase inhibitors

ELEK

Milica

The SF5 moiety as promising substituent for the design of
novel D2 and D3 receptors ligands

FILIPOVIC

Nenad

A novel binuclear hydrazone-based Cd(II) complex is a strong pro-apoptotic inducer with significant activity against 2D and 3D pancreatic cancer stem cells

FOIS

Benedetta

Heterocyclic amides as selective inhibitors of HRV-B replication

HYERACI

Mariafrancesca

New complexes of platinum(II): effects on sensitive and resistant cells New complexes of platinum(II): effects on sensitive and resistant cells

JUHAS

Martin

Design, synthesis and biological evaluation of pyrazine derivatives

KRATKY

Martin

Conjugates of tuftsin-based peptide carriers and phenolic antitubercular molecules

LANZILLOTTA

Daria

The CD98hc oncoprotein as a target of novel anticancer therapeutic approachesagents

LIN

Cai

Discovery of pyrrolo[2,3-b]pyridine nucleoside analogues as anti-Trypanosomacruzi agents

MANCUSO

Francesca

Design and synthesis of new potential theranostic agents targeting tumor-expressed carbonic anhydrase IX and XII

MANCUSO

Stefano

New strategies for the multistep synthesis of oleocanthal

MARTINS

Daniel

Toxicological profile of phenethylamine-based psychoactive drugs

MARUCA

Annalisa

Computational methods to identify bioactive food constituents with potential Multi-Targeting profile

MELEDDU

Rita

Identification of potent and selective MAO-B inhibitors

MORACA

Federica

Design, synthesis and biological evaluation of Exemestane derivatives as potent inhibitors of Aromatase

NOVELLI

Paolo

Synthesis of a new cross-bridged cyclam radiotracer for PET detection of PD-L1 cancer expression.

OBLAK

Domen

3D pharmacophore modeling of DHODH as an antimalarial target using LigandScout

OCCHIUZZI

Maria Antonietta

Lipid lowering and antiglycaemic properties of Tacle®

by in vitro and in vivo investigation

OLIVEIRA

Catarina

Benzoic acid-derived nitrones: a new class of acetylcholinesterase inhibitors and potential neuroprotective agents

PARISE

Angela

Arsenous acid-platinum(II) a new dual pharmacophore anti-cancer agent: computational insights

PETROU

Anthi

Molecular docking and design of novel 2, 3-aryl-thiazolidin-4-ones as potent NNRTIs inhibitors

PFLEGR

Vaclav

Synthesis and evaluation of novel antimycobacterial isoniazid analogues

PINTO

Miguel

De-risking tolcapone hepatotoxicity for repurposing therapy using a nanotechnological approach

PROCOPIO

Anna Caterina

In silico  identification of new aromatase inhibitors

PUIG DE LA BELLACASA

Raimon

An in vivo biologically active pyrido[2,3-d]pyrimidine as a KRAS and tyrosine kinase inhibitor for the potential treatment of lung cancer

RITACCA

Alessandra

Can boron-containing compounds be considered new structural scaffolds for the treatment of Alzheimer’s disease?

ROCCA

Roberta

Identification of small molecules with specific interference to lncRNA activity through different computational approaches

ROMEO

Isabella

Mechanistic insights of hydrolytic activity into a de novo functional protein framework.

SEQUEIRA

Lisa

Synthesis of furochromone derivatives with potential anticancer activity

SESTITO

Simona

Computational conception and chemical synthesis of dual BTK-TCL1 inhibitors

STRASZAK

Dominik

New route for the synthesis of 1-(arylimidazolin-2-yl)-3-arylureas

TALLARICO

Sofia

Combined ultrasound/microwave chemocatalytic method for selective conversion of cellulose into lactic acid

TORRES VARGAS

Jose Antonio

Biological activity of toluquinol derivatives

VITTORIO

Serena

In silico  studies for the discovery of MUC1/CIN85 protein-protein interaction inhibitors as anti-metastatic agents

YETIK ANACAK

Gunay

A new synthesized AChE inhibitor induces H2S formation in the brain

MuTaLig

With the support of:

UMG

Dipartimento di Scienze della Salute

PhD

FUMG

ORDINE FARMACISTI CZ

FONDAZIONE CADUCEO

Correale

EJMEDCHEM

S-IN

EXACTAOPTECH